# Rimonci Capital

Rimonci Capital is a Private Equity based in Beijing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** rimonci.com
- **LinkedIn:** https://www.linkedin.com/company/rimonci-capital

## Regulatory record

- **Reports private funds:** No

## About

Rimonci Capital focuses on China-Israel cross-border investment, financial advisory, business development, and technology transfer. The firm manages its own funds, primarily in medical devices and cybersecurity. Rimonci Capital has made 12 investments, including a Seed VC investment in Laclaree on January 28, 2025.

## Sectors

- Healthcare Services
- Medical Devices

## Questions

### What is Rimonci Capital's investment focus?

Rimonci Capital invests exclusively in the ophthalmology and vision care sector, covering medical devices, pharmaceuticals, diagnostics, and digital health within eye care. It deploys capital across venture, growth, and buyout stages, as well as through fund-of-fund commitments. The firm's mandate spans China, the United States, and Europe.

### Who founded Rimonci Capital and who runs the firm?

Specific founder and leadership details are not publicly documented in English-language sources. The firm operates out of Beijing and is known within the ophthalmic industry for its investment activities and its annual ophthalmology investment summit, but it has not widely published executive biographies or team profiles.

### Does Rimonci Capital invest directly in companies or through funds?

Rimonci Capital employs a hybrid approach, making direct investments in ophthalmic companies across early-stage, growth, and buyout stages, while also allocating capital through fund-of-funds commitments. This dual strategy allows it to back both specific companies and broader portfolios within the vision care ecosystem.

### How does Rimonci Capital source its investment opportunities?

Rimonci's sourcing model relies heavily on its deep specialization in ophthalmology and its convening power through the annual investment summit. The firm's narrow focus gives it visibility into clinical and commercial developments across the vision care sector, while its cross-border presence helps it identify companies seeking access to the Chinese market or international expansion.

## Related profiles

- [Rimal Capital](https://altss.com/profile/rimal-capital)
- [Rimon Group](https://altss.com/profile/rimon-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/rimonci-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology